Contribution of rare and common coding variants to haematological malignancies in the UK biobank

Affiliations

¹ Center for Primary Health Care Research, Department of Clinical Sciences, Lund University and Region Skåne, Malmö, Sweden.
² Department of Environmental Science and Bioscience, Kristianstad University, Kristianstad, Sweden.

Bengt Zöller et al. Leuk Res Rep. 2023.

. 2023 Jan 10:19:100362.

doi: 10.1016/j.lrr.2023.100362. eCollection 2023.

¹ Center for Primary Health Care Research, Department of Clinical Sciences, Lund University and Region Skåne, Malmö, Sweden.
² Department of Environmental Science and Bioscience, Kristianstad University, Kristianstad, Sweden.

No abstract available

Keywords: Genetics; Hematologic neoplasms; Mutation; Whole exome sequencing.

Conflict of interest statement

None

1. Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann. Oncol. 2007;18:I3–I8. - PubMed
1. Sud A, Chattopadhyay S, Thomsen H, et al. Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk. Blood. 2019;134:960–969. - PMC - PubMed
1. Wang Q, Dhindsa RS, Carss K, et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature. 2021;597:527–532. - PMC - PubMed
1. Karczewski K.J., Solomonson M., Chao, et al. Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes. Cell Genomics. 2022;2 - PMC - PubMed
1. Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130:410–423. - PMC - PubMed